University of California, San Diego

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).

775 total trials 143 currently recruiting 499 completed early-phase tilt top decile by trial count

University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.

University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.

Top-decile sponsor footprint

University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

775 total, page 12 of 16

COMPLETED Phase 4

Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks

NCT01898689

COMPLETED NA

Alternative Treatments for Premenstrual Dysphoric Disorder

NCT01799733

COMPLETED NA

AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals

NCT02154750

COMPLETED NA

Counseling on the Interaction of Hormonal Contraceptives and Antiepileptics

NCT02485756

COMPLETED NA

Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.

NCT02166762

COMPLETED NA

Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)

NCT01837147

COMPLETED NA

Acupuncture Therapy for Treatment of Musculoskeletal Pain

NCT02263001

COMPLETED Phase 3

Providing Free Nicotine Patches to Quitline Smokers

NCT01736085

COMPLETED NA

Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia

NCT02136212

COMPLETED NA

Validating Machine -Learned Classifiers of Sedentary Behavior and Physical Activity

NCT01775826

COMPLETED NA

Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men

NCT01694121

COMPLETED Phase 2

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

NCT01766713

COMPLETED

Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients

NCT04462081

COMPLETED NA

Fitbit One and Text Messaging Prompts to Promote Physical Activity in Overweight/Obese Adults

NCT02188875

COMPLETED

Brain Radiation Exposure and Attenuation During Invasive Cardiology Procedures

NCT01910272

COMPLETED Phase 4

CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM

NCT01761643

COMPLETED Phase 4

Femoral Versus Adductor Canal Continuous Peripheral Nerve Blocks for Knee Arthroplasty

NCT01759277

COMPLETED NA

Nutrigenomics: Personalizing Weight Loss for Obese Veterans

NCT01859403

COMPLETED Phase 4

A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial

NCT01696214

COMPLETED NA

Learning Theory to Improve Obesity Treatment

NCT01708785

COMPLETED NA

Facilitating Adolescent Self-Change for Alcohol Problems

NCT01690026

TERMINATED Phase 2

A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies

NCT02623439

COMPLETED

Detection and Management of Non-Compressible Hemorrhage by Vena Cava Ultrasonography

NCT01989273

COMPLETED NA

Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and Function

NCT01671514

COMPLETED NA

Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation

NCT02106663

COMPLETED Phase 1

Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities

NCT01431105

COMPLETED Phase 3

A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline

NCT01502306

COMPLETED

Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury

NCT01589172

COMPLETED NA

Effectiveness and Implementation of a Mental Health Intervention for ASD

NCT02416323

COMPLETED NA

EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT

NCT02293213

COMPLETED NA

Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis

NCT03177655

TERMINATED NA

Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia

NCT02144155

TERMINATED Phase 3

Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections

NCT01483872

COMPLETED NA

UCSD Take Charge Study

NCT01345500

COMPLETED Phase 1

EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks

NCT01349140

COMPLETED NA

Increasing Contraception Utilization Among Women Prescribed Teratogenic Medications

NCT01624155

COMPLETED NA

Novel Dietary Interventions for Treating Insulin Resistance

NCT02006394

COMPLETED NA

Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent

NCT02080312

COMPLETED NA

Metabolism, Exercise and Nutrition at UCSD (MENU Study)

NCT01424007

COMPLETED NA

Pasos Hacia La Salud - Physical Activity Intervention for Latinas

NCT01834287

TERMINATED NA

Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

NCT01293123

COMPLETED Phase 1

Treatment Study for Rural Latino Youth With Anxiety

NCT01491880

COMPLETED Phase 2

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

NCT01554397

COMPLETED Phase 4

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure

NCT01472692

COMPLETED

STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk

NCT01442896

COMPLETED NA

Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™

NCT01432561

COMPLETED

Validation of Objective Measures of Place-Based Physical Activity

NCT01886261

COMPLETED NA

The Effects of the Water Drinking Test on Intraocular Pressure

NCT01507584

COMPLETED NA

Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation

NCT02111993

COMPLETED Phase 3

Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)

NCT01154192

← Previous Page 12 of 16 Next →

Phase Distribution

PhaseTrial count
Phase 1 80
Phase 2 90
Phase 3 22
Phase 4 82

What is open in the University of California, San Diego pipeline

143 recruiting of 775 indexed (18% open); 499 completed (64%).

Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).

Top condition: Anorexia Nervosa (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, San Diego: open-pipeline peers nationwide

Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of California, San DiegoDana-Farber Cancer InstituteMedical University of South CarolinaUniversity of ChicagoUniversity of UtahNeurocrine BiosciencesThomas Jefferson UniversityAbramson Cancer Center at Penn MedicineUniversity of Maryland, Baltimore
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 775 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University of California, San Diego page

775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.

  • 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.